For any questions, please contact the QM Division.
Message from the Office of Developmental Programs (ODP):
As a result of the COVID-19 pandemic, the Office of Developmental Programs (ODP) received approval from the Centers for Medicare and Medicaid Services (CMS) to delay the Quality Assessment and Improvement (QA&I) activities associated to Cycle 2, Year 1 until July 1, 2022. For FY 2021–2022, ODP will be conducting a second interim review process with several temporarily modified QA&I activities of Administrative Entities (AE), Supports Coordination Organizations (SCO), and Providers; which includes Agency with Choice (AWC) Financial Management Services (FMS) Providers.
The QA&I Interim Year 2 review process is used to demonstrate outcomes in the following areas: CMS Performance Measures, Information Sharing Advisory Committee (ISAC) recommendations, health and welfare, and ODP priorities. It also serves to validate an entity’s adherence with federal and state requirements.
During Interim Year 2, AEs, SCOs and Providers identified in the sample will not receive a traditional onsite review as all activities will occur remotely to include a virtual conference and virtual follow-up meetings if necessary.
Attached please find the updated QA&I Interim Year 2 Review Process Document that includes the changes highlighted in yellow. This document will provide important information for stakeholders to complete the process successfully.
ODP recognizes the many ongoing challenges providers, SCOs, and AEs are managing related to the COVID-19 pandemic; thank you for your continued commitment to supporting individuals with and intellectual disability and autism.
Monday, July 19, 2021
2:30 pm–4:00 pm
Tuesday, July 20, 2021
9:00 am–10:30 am
This training session will provide an overview of the Office of Developmental Programs’ (ODP) QA&I Interim Year 2 Review Process for Fiscal Year (FY) 2021–2022. ODP encourages all Administrative Entity, Supports Coordination Organizations, and Provider QA&I leads to join the session. For more information on the ODP QA&I Interim Year 2 Review Process, see ODP Announcement 21-052; the link to the announcement is here. Also, please read the Pennsylvania Office of Developmental Program’s Quality Assessment and Improvement FY 21–22 Interim Year 2 Review Process document distributed to all stakeholders on July 7, 2021 prior to participating in the training. There is a link to the process document available here.
In addition, only register for one training session at the follow links:
ODP Announcement 21-052 communicates the planned commencement of an Office of Developmental Programs (ODP) Quality Assessment and Improvement (QA&I) interim review process for Fiscal Year (FY) 2021–2022 as a result of the impact of the COVID-19 pandemic. ODP received approval from the Centers for Medicare and Medicaid Services (CMS) through an Appendix K amendment to conduct a QA&I “interim” review for FY 2021–2022 and to delay the implementation of Cycle 2, Year 1 activities until FY 2022–2023. The Quality Assessment and Improvement (QAI) Interim Year 2 Review Process Document provides detailed guidance for the ODP’s Quality Assessment and Improvement (QA&I) interim review process for Fiscal Year (FY) 2021-2022. The following is a summary of the approved changes for the interim review period.
Desk and Onsite Reviews
Entrance and Exit Conferences
QA&I Spreadsheet and Corrective Action Plan (CAP)
Please note that the activities detailed in this announcement are subject to change. Once the updated resources and materials for the Interim Year 2 review are finalized, an email will be sent to all primary and secondary QA&I contacts noting their availability on the MyODP Training & Resource Center using the following path: Resources > ODP Information > QA&I Process.
ODP will be offering Interim Year 2 training opportunities in July 2021. Details regarding these trainings will be forthcoming.
Please send questions via email directly to the QA&I Process Mailbox.